CPR volume exchanger valve system with safety feature and methods

Information

  • Patent Grant
  • 9675770
  • Patent Number
    9,675,770
  • Date Filed
    Monday, March 2, 2015
    9 years ago
  • Date Issued
    Tuesday, June 13, 2017
    7 years ago
Abstract
A method for regulating gas flows into and out of a patient includes repetitively forcing respiratory gases out of the lungs. Respiratory gases are prevented from entering back into the lungs during a time between when respiratory gases are forced out of the lungs. Periodically, an oxygen-containing gas is supplied to the lungs.
Description
BACKGROUND OF THE INVENTION

This invention relates generally to the field of cardiopulmonary resuscitation, and in particular to techniques to increase circulation when performing CPR.


Despite current methods of CPR most people die after cardiac arrest. One of the major reasons is that blood flow to the heart and brain is very poor with traditional manual closed chest CPR. Greater circulation of blood during CPR will result in improved outcomes.


BRIEF SUMMARY OF THE INVENTION

In some embodiments, methods are described for regulating gas flows into and out of a patient. According to one method, respiratory gases are repetitively forced out of the lungs. Respiratory gases are also prevented from entering back into the lungs between chest compressions. Periodically, an oxygen-containing gas is supplied to the lungs to provide ventilation.


In one particular aspect, the gases are repetitively forced out of the lungs by repetitively compressing the chest and permitting the chest to recoil a rate of about 60 to about 120 times/min. In a further aspect, a low flow and volume of oxygen is continuously supplied to the lungs. This volume of oxygen is less than the volume of respiratory gases expelled with successive chest compressions so that the number of times that the lungs are expanded with oxygen-containing gases is reduced by the low level of continuous oxygen insufflation.


Other embodiments of this invention include methods and devices for increasing circulation during CPR by reducing the volume of air in the lungs during chest compressions so that the thorax has more space to permit more blood flow into the heart with each chest compression/chest recoil cycle. Such embodiments include ways to compress the chest and allow it to recoil. During each compression, air is pushed out of the lungs through a one way valve. Every time the chest wall recoils following a compression, air (or respiratory gases) from outside the patient is prevented from passively entering the lungs. With sequential compressions, less and less air remains in the thorax. This gradual extrusion of respiratory gases from the lungs with each chest compression results in more space within the thorax (lungs, blood vessels, and heart) to be filled with blood. With more blood in the chest and less air, each time the chest is compressed more blood is ejected from the heart. After some number of compressions, such as between about 12 and about 30 (depending upon how many people are performing CPR and if the airway is secured with a face mask versus and endotracheal tube or equivalent), air is allowed to actively enter the lungs either by the delivery of a positive pressure breath from a ventilation source or by negative pressure ventilation (e.g. an iron lung or equivalent).


One advantage of such techniques is that during the chest recoil, intracranial pressures are decreased more rapidly and to a lower value, thereby further increasing the duration and magnitude of cerebral perfusion pressure.


In one particular aspect, the volume of respiratory gas expelled over a series of chest compression/recoil cycles is in the range from about 1 to about 15 cc/kg. Also, the volume of respiratory gases expelled from the chest may be expelled against a low level of fixed or variable resistance that is in the range from about 0 cm H2O to about 10 cm H2O.


In a further embodiment, the invention provides an exemplary device to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest. The device comprises a housing having a rescuer port and a patient port. A valve system is disposed in the housing. Further, the housing and the valve system are configured such that a volume of respiratory gas expelled from the lungs during each chest compression enters the housing through the patient port, passes through the valve system and exits the rescuer port. Also, when the chest wall recoils, oxygen containing gases are prevented from entering the lungs through the patient port by the valve system. A ventilation source may also be used to inject an oxygen-containing gas into the housing which passes through the valve system, through the patient port and to the patient to periodically expand the lungs with the oxygen-containing gases.


The valve system may be constructed using a variety of valves, such as check valves, spring valves, duck valves, electronically-controlled valves and the like. As another example, a pair of one way valves may be used that are separately configured to open with opposite gas flows passing through the housing. Also, a variety of ventilation sources may be used, such as mouth-to-mouth ventilation, a mouth-mask, a resuscitator bag, an automatic ventilator, a semi-automatic ventilator, a body cuirass, an iron-lung device and the like. In another aspect, the valve system may include a means to impede the exodus of respiratory gases from the lungs with a fixed or variable resistance that is in the range from about 0 cm H2O to about 10 cm H2O.


In one particular arrangement, at least one physiological sensor may be used to measure one or more physiological parameters. Such sensors may include electrocardiogram signal sensors, impedance sensors to detect air/blood ratio in the thorax, and the like. Also, a communication system may be employed to permit signals from the physiological sensor(s) to be transmitted to a CPR device used during resuscitation to provide various types of feedback. This can include how to perform CPR, an optimal time to actively inflate the lungs with respiratory gases, an optimal time to defibrillate, and the like. Further, timing lights may be employed to assist a rescuer in performing CPR, such as when to provide chest compressions.


In a further aspect, a supply system may be used to deliver a low flow and volume of continuous oxygen into the lungs which is less than the volume of respiratory gases expelled with successive chest compressions. In this way, the number of times that the lungs are expanded with oxygen-containing gases is reduced by the low level of continuous oxygen insufflation.


In still another embodiment, the invention provides a device to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest. The device comprises a housing having a rescuer port and a patient port. Means are provided for regulating gas flows through the housing such that a volume of respiratory gas expelled from the lungs during each chest compression enters the housing through the patient port and exits the rescuer port. Also, when the chest wall recoils, oxygen containing gases are prevented from entering the lungs through the patient port. A ventilation source is employed to inject an oxygen-containing gas into the housing and to pass through the patient port and to the patient to periodically expand the lungs with the oxygen-containing gases.


In one aspect, the means for regulating gas flows comprises a pair of one way valves that are separately configured to open with opposite gas flows through the housing.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a graph illustrating lung volume while performing CPR when applying techniques according to the invention.



FIG. 2A schematically illustrates expired respiratory gases passing through a valve system during a chest compression according to the invention, along with a control system and a sensor.



FIG. 2B schematically illustrates how respiratory gases are prevented from passing through the valve system and into the lungs during chest recoil or chest decompression according to the invention.



FIG. 2C schematically illustrates the injection of an oxygen-containing gas through the valve system to provide patient ventilation according to the invention.



FIG. 2D schematically illustrates the passage of respiratory gases through a safety check valve if the patient inspires according to the invention.



FIG. 3A illustrates one embodiment of a valve system according to the invention.



FIG. 3B is a cross sectional side view of the valve system of FIG. 3A illustrating gas flows with patient exhalation (such as during a chest compression), along with a control system and a sensor.



FIG. 3C is a cross sectional side view of the valve system of FIG. 3A illustrating the absence of gas flow when the patient's chest recoils or is lifted.



FIG. 3D is a cross sectional side view of the valve system of FIG. 3A illustrating gas flows when delivering an oxygen-containing gas to the patient.



FIG. 4 is a flow chart illustrating one method for performing CPR according to the invention.





DETAILED DESCRIPTION OF THE INVENTION

Multiple methods of chest compression may be used when performing CPR in patients in cardiac arrest. In this life-threatening situation, the heart is not capable of circulating blood so non-invasive external means are used to assist in the circulation of blood to the vital organs including the heart, lungs, and brain. The methods and devices that may be used to circulate blood during cardiac arrest include manual closed chest CPR, active compression decompression (ACD) CPR where the patient's chest is actively pulled upward (including by use of a mechanical assistance device that is adhered to the chest) to achieve complete chest wall recoil, mechanical CPR with manual or automated devices that compress the chest and either allow the chest to recoil passively or actively, and devices that compress the chest wall and then function like an iron lung and actively expand the thoracic cage. Some of these approaches and devices only compress the anterior aspect of the chest such as the sternum while other approaches and devices compress all or part of the thorax circumferentially. Some approaches and devices also compress the thorax and abdomen in an alternating sequence. Some approaches also involve compressing the lower extremities to enhance venous blood flow back to the heart and augment arterial pressure so that more blood goes to the brain. Some approaches also involve compressing the back, with the patient lying on his/her stomach. Some devices include both non-invasive methods and devices outlined above that are coupled with invasive devices, such as an intra-aortic balloon, and devices to simultaneously cool the patient


Because the cardiac valves remain essentially intact during CPR, blood is pushed out of the heart into the aorta during the chest compression phase of CPR. When the chest wall recoils, blood from extrathoracic compartments (e.g. the abdomen, upper limbs, and head) enters the thorax, specifically the heart and lungs. Without the next chest compression, the blood would pool in the heart and lungs during cardiac arrest as there is insufficient intrinsic cardiac pump activity to promote forward blood flow. Thus, chest compressions are an essential part of CPR.


During the compression phase air is pushed out of the thorax and into the atmosphere via the trachea and airways. During the decompression phase it passively returns back into the thorax via the same airway system. As such, respiratory gases move out of and back into the thorax. With each compression the pressure within the chest is nearly instantaneously transmitted to the heart and also to the brain via the spinal column and via vascular connections. Thus, with each external chest compression pressure in the thorax and within all of the organs in the thorax is increased. Application of the methods and devices described in this application, in conjunction with any of the methods of CPR noted above, result in less and less air in the thorax, making room for more and more blood to return to the heart during the chest wall recoil phase. This increases circulation to the coronary arteries and lowers intracranial pressure during the chest wall decompression phase and with each subsequent compression increases blood flow to the vital organs, especially the brain. Since the delivery of oxygen is an important aspect of CPR, periodically a positive pressure ventilation needs to be delivered to inflate the lungs and provide oxygen. The lungs can also be inflated by periodic negative pressure ventilation with, for example, an iron lung or chest cuirass device. With both positive and negative pressure ventilation, typically a patient receives a tidal volume of about 500-1000 cc during each active ventilation (positive pressure ventilation). Thus, with the practice of this invention, an equal volume of respiratory gas is extruded from lungs over the course of several compressions so that after about 2 to 6 compressions the delivered volume has been removed from the thorax and its space can be replaced by blood that refills the thoracic space. This exchange is made possible by the fact that pressures within the thorax are transduced from one organ to another nearly instantaneously. This pressure transfer occurs between different thoracic compartments, for example the lungs and the right heart, very rapidly, especially between organs in the thorax with a high degree of compliance. For example, positive pressures are transferred during the compression phase from the lungs to the right heart, and as such right heart pressures are markedly increased with each chest compression. The increase in pressure within the lungs is transferred to the heart, propelling blood within the heart chambers in a forward direction along the course from right atrium to right ventricle to pulmonary artery pulmonary vein, left ventricle, and out the aorta. The inverse is also true, with chest wall recoil the negative pressures are transmitted throughout the thorax, including the spinal cord. This pulls blood into the heart and lungs from outside the thorax. The decreases in pressures within the thorax are augmented by the methods and devices described herein. The more gas that is pushed out of the lungs with each compression and not allowed back in, the more space is made available for blood to flow into the organs within the thorax each time the chest wall recoils. The volume of respiratory gas that is expelled over a series of chest compression/recoil cycles may be about 5 to about 15 cc/kg. It would typically be expelled after about 2 to 6 compression/recoil cycles. The volume of air expelled from the chest could be expelled against a low level of fixed or variable resistance, typically in the range from about 0 cm H2O to about 10 cm H2O. This could be adjustable and could be provided by a valving system or other means having a low flow of positive pressure gases, such as oxygen. This process can be further augmented by active compressions and active decompressions. This process can also be further augmented by actively extracting a volume of respiratory gases between positive pressure breaths, creating even more space in the thorax to be filled with blood with each decompression phase of CPR to prime the heart for the next compression.


Periodically the lungs need to be inflated so that the pulmonary vascular resistance (blood pressure in the blood vessels in the lungs) does not get too high (which happens when the lungs are empty and collapse) which would limit blood flow through the lungs. Periodic inflation of the lungs also provides oxygen and helps to clear carbon dioxide. This process is depicted graphically in FIG. 1. The left-Y axis shows the volume of respiratory gas in the lungs in liters and the X axis shows time in seconds. At point A, a positive pressure breath is delivered. Down and up arrows show when chest compression and decompression (in this example passive chest wall recoil) occurs. Changes in the volumes of respiratory gases in the lungs when using the invention are shown by the solid line. With each chest compression air is pushed out of the lungs, and not allowed back into the lungs because of the valve system. This results in a progressive decrease in respiratory gases within the lungs. The shaded area, labeled B, is the volume of respiratory gas that is expelled from the lungs with each chest compression. The total volume, shown by B, creates space that is filled by more blood returning to the heart and lungs during the decompression phase whenever a positive pressure is not being applied to the thorax by chest compressions. By contrast, changes in the volumes of respiratory gases in the lungs without the invention are shown by the hashed line. Each compression and chest wall recoil cycle is associated with a slight increase and decrease in pressures in the airway as respiratory gases move freely into and out of the lungs with each decompression and compression cycle.


A variety of valves may be coupled to the patient's airway to permit respiratory gases to escape from the lungs during chest compressions, while permitting periodic ventilation. One type of valve could be a one-way valve, typically used in combination with another one-way valve that opens in the opposite direction and which is biased in the closed position so that gases cannot enter the lungs during chest recoil or chest decompression. Another valve system that may be used is described in U.S. Pat. Nos. 5,692,498; 6,062,219; 6,526,973; and 6,604,523, incorporated herein by reference. With such valves, the threshold cracking pressure could be set high enough so that respiratory gases were always prevented from entering into the lungs until actively ventilated.


Airflow into and out of the chest through one embodiment of the invention is shown schematically in FIGS. 2A-C. In FIG. 2A, a valve system 10 is schematically illustrated. Valve system 10 has a patient port 12 which interfaces with the patient's airway and a rescuer port 14 used by a rescuer to provide ventilation to the patient. When the chest is compressed (as illustrated by the hands pressing down on the chest wall), respiratory gases flow from the patient through the valve system 10 as shown by the arrow. In so doing, the respiratory gases pass into room air with minimal or no resistance from valve system 10. In FIG. 2B, the chest wall recoils during the decompression phase as the rescuer's hands are lifted (or the chest is actively lifted upward). Now, valve system 10 prevents respiratory gases from entering the patient. In FIG. 2C a positive pressure ventilation is delivered through rescuer port 14 wherein passes through valve system 109 and outpatient port 12 where is passes to the patient's lungs. As such, with each chest compression, more and more gases are forced out of the lungs. This is because during decompression, gases are prevented from entering. When needed, gases can be injected into the lungs to provide adequate ventilation.


In some cases, the patient may begin to breathe or gasp spontaneously. As shown in FIG. 2D, valve system 10 has one or more safety check valves 16 to permit gases to pass through patient port 12 and into the lungs. As one example, safety check valves 16 may be set to open at about −10 cm H2O. This schematic is not meant to be limiting but rather demonstrative of airflow through one potential embodiment of the invention during CPR.


The invention may employ a variety of techniques to enhance circulation. For example, a device to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest may be configured to allow a volume of respiratory gas from the lungs to exit the airway with each external chest compression but prevents oxygen containing gases from passively reentering the lungs each time the chest wall recoils. This may be done using a valve system having a one-way valve and a means to periodically expand the lungs with oxygen-containing gases. Such a device may be particularly useful when the chest is compressed and allowed to recoil at a rate of about 60 to about 120 times/min. Such a device may also permit a volume of respiratory gases to be expelled from the lungs with each compression. Such a device can be used with manual CPR, ACD CPR, manually operated CPR devices, or automated CPR devices. With each chest wall recoil, respiratory gases are prevented from returning to the lungs by means of a one-way valve. Over each successive chest compression/chest recoil cycle there is a successive decrease in respiratory gases within the lungs. Periodically, the lungs are actively expanded with oxygen-containing gas.


The valve system can be made of one or more check valves, spring valves, duck valves, other mechanical or electronically controlled valves and switches. The lungs are periodically expanded by a ventilation source that could include: mouth-mouth ventilation, mouth-mask, a resuscitator bag, an automatic or semi-automatic ventilator, a body cuirass or iron-lung like device or the like. A variety of sensors could be incorporated into the system to guide the ventilation rate and/or determine the degree of chest compression and/or degree of chest wall recoil including: airway pressure sensors, carbon dioxide sensors, and/or impedance sensors to detect air/blood ratio in the thorax to help guide ventilation and compression rate.


The valve system could include a one-way valve with a means to impede exhalation or the exodus of respiratory gases with a fixed or variable resistance. This could be in the range from about 0 to about 20 cm H2O, and in some cases about 0 to about 10 cm H20. This may also be adjustable. In some cases such expiratory resistance helps to push blood out of the lungs back into the left heart, and serves as a means to help prevent buildup of blood in the lungs during CPR.


One particular embodiment of a valve system 20 is shown in FIG. 3A. Valve system 20 is constructed of a housing, which is conveniently manufactured as an inspiration interface housing 22 and a patient interface housing 24. A ventilation source port 26 for ventilation to the patient is included in housing 22 while a connector port 28 is included in housing 24. In this way, a ventilation source may be coupled to port 26 and port 28 may be used to interface with the patient, and the patient's airway. A valve plate 30 having a pair of one-way check valves 32 and 34 in between.


As shown in FIG. 3B, during chest compression, respiratory gases flow from the patient and pass through port 28 where the gases open expiratory check valve 34. From there, the gases exhaust to the atmosphere through port 26. Optionally, valve 34 may be biased in the closed position, and may open when the exiting gases exert a pressure that is less than about 20 cm H2O.


Port 28 may be coupled to a patient interface 21, which could include a facial mask, endotracheal tube, other airway device or any of the other interfaces described herein. Port 26 may be coupled to a ventilation source 23, such as a ventilator bag, ventilator, tube for performing mouth-to-mouth resuscitation, or any of the other devices described herein.


Further, a controller 25 may be employed to control any of the electronic equipment. Controller 25 may include a storage device, such as memory, one or more processors and appropriate hardware and/or software for performing operations under the direction of the processor. For example, if ventilation source 23 were a ventilator, controller 25 may be employed to control operation of the ventilator. One or more sensors 27 may be coupled to controller to monitor various physiological parameters of the patient as described herein. Also, controller 25 could modify application of chest compressions and/or ventilations based on the sensed parameters.


Controller 25 may also be coupled to one or more timing lights 29 which could be used to indicate to a rescuer as to when to provide chest compressions and/or ventilations.


In FIG. 3C, the chest wall recoils. Inspiratory check valve 32 is biased in the closed position, by use of a spring, elastomer or the like, so that no respiratory gases are allow through inspiratory check valve 32. Valve 32 may be biased closed until a pressure in the range of about −5 to about −10 mmHg is achieved. This is most likely to occur when the patient takes a spontaneous gasp during CPR, and then airflow moves through the inspiratory check valve 32 to the patient through port 28. This can also occur if a rescuer ventilates the patient rapidly with a large tidal volume rapidly through port 26 as shown in FIG. 3D.


Any of the valve systems described herein could also include or be associated with physiological sensors, timing lights, impedance sensors to detect air/blood ratio in the thorax, and a way to communicate with a CPR device or other apparatus used during resuscitation (e.g. defibrillator) to provide feedback in terms of how to perform CPR, the optimal time to actively inflate the lungs with respiratory gases or the optimal time to defibrillate.


The valve systems or associated devices could also include a way to deliver a low flow and volume of continuous oxygen into the lungs which is less than or just equal to the total volume of the expelled volume of respiratory gases with chest compressions so that the number of times that the lungs are expanded with oxygen-rich gases is reduced by the low level of continuous oxygen insufflation.


One exemplary method for controlling gas flow into and out of a patient's lungs is illustrated in FIG. 4. At step 40, cardiopulmonary resuscitation is performed on a patient in cardiac arrest. This may be performed by compressing the chest and allowing the chest to recoil at a rate of about 60 to about 120 times/min.


For a plurality of chest recoils, respiratory gases are prevented from returning to the lungs such that over successive chest compression/chest recoil cycles there is a successive decrease in respiratory gases within the lungs (see step 42). This allows more blood to enter the thoracic space (the volume of respiratory gas expelled over a series of chest compression/recoil cycles optionally being in the range from about 4 to about 15 cc/kg). Hence, over each successive chest compression/chest recoil cycle there is a successive decrease in respiratory gases within the lungs thereby allowing more blood to enter the thoracic space.


Periodically, the patient may be ventilated (see step 46), such as by periodically actively expanding the lungs with an oxygen-containing gas. During the chest recoil phase of CPR, intracranial pressures are decreased more rapidly and to a lower value thereby further increasing the duration and magnitude of cerebral perfusion pressure. Optionally, the volume of respiratory gas expelled from the chest may be expelled against a low level of fixed or variable resistance that is in the range from about 0 to about 10 cm H2O (see step 48).


The devices and methods described herein may be used with any type of CPR technique that involves manipulation of the chest to change pressures within the thorax would benefit from this improved method of invention. Also, the method for providing periodic expansion of the lungs could include mouth-mouth ventilation, a resuscitator bag, an automatic or semi-automatic ventilator, a body cuirass or iron-lung like device. The method could also include a way to deliver a low flow and volume of continuous oxygen into the lungs which is less than the total volume of the expelled volume of respiratory gases so that the frequency of positive pressure ventilations by an external ventilation source could be reduced by the low level of continuous oxygen insufflation (see step 50).


A variety of sensors could be used to guide the periodic ventilation rate or determine the degree of chest compression or degree of chest wall recoil. Sensors could include airway pressure sensors, timing lights, carbon dioxide sensor, electrocardiogram signal sensors, and/or impedance sensors to detect air/blood ratio in the thorax to help guide ventilation and compression rate and determine if CPR should be continued, the optimal time and way to defibrillate, and when to stop CPR efforts because of futility.


The method could include a number of different airway adjuncts to maintain a seal between the trachea and the ventilation source or pharynx and ventilation source or mouth and ventilation source (e.g. endotracheal tube, face mask, laryngeal mask airway, supraglottic airway, and the like). Sensors within these airways could be used to verify proper airway adjunct placement. Such sensors could include a carbon dioxide detector which could be housed in a manner that is protected from bodily fluids.


The method could include a means to transmit the amount of respiratory gas volume delivered or expelled from the chest to a monitoring system that could be used as part of a closed loop circuit to maximize the number of compressions interspersed between active ventilations in order to maximize circulation during CPR. Circulation during CPR could be measured by a variety of means including measurement of end tidal carbon dioxide, the change in expired end tidal carbon dioxide levels over a given time interval, a change in impedance within the body, and changes in other physiological parameters such as temperature.


In some embodiments, the invention provides the ability to utilize one or more sensors that are associated with the valve systems described herein to indirectly measure the rate and depth of chest compression. For instance, the sensors may measure the respiratory gases (also referred to as “air”) delivered to the patient, the airway pressure and the like, and then used to estimate the rate and depth of chest compression. This provides a convenient way to measure the quality of CPR. This may be done, for example, by comparing variations in amount of air delivered (or airway pressure) produced by positive-pressure ventilation to the air expelled (or airway pressure variations) produced during chest compressions. This provides an easy way to monitor, analyze and report the depth of compressions, particularly to the user in real time. This feedback allows the user an opportunity to continuously adjust or change the depth of manual (or automatic) compressions to achieve a targeted depth of compressions. Also, the pressure or volume of air generated by positive-pressure ventilation or delivered by a manual resuscitation bag can be analyzed and reported to the caregiver for monitoring and adjustment purposes. In addition to calculations which report actual compression depth and breathing pressure, the frequency and duration of both breaths and compressions can be monitored and reported to the user. Hence, frequency of compressions and ventilation can be controlled to provide a targeted frequency or rate.


As one example, measurements may be taken using one or more sensors disposed anywhere within valve system 20, such as within the housing or one of the valves. For example, a sensor could be disposed in inspiration interface housing 22 or in patient interface housing 24. As another option, the sensor could be positioned within ventilation source port 26, or within one-way check valves 32 or 34. Pressure or air volume measurements may be transmitted to a controller, such as controller 25, either wirelessly or by a wired connection. Controller 25 may be programmed to determine the depth of chest compressions, timing, frequency, and the like, as described above using the pressure or air volume readings. Further, various visual and/or audio signals may be provided to the rescuer giving feedback as to depth or compressions, rate of compressions, rate of ventilation and the like. Controller 25 may be programmed to provide this feedback, such as to timing lights, computer display screens, speakers, and the like.


The invention has now been described in detail for purposes of clarity and understanding. However, it will be appreciated that certain changes and modifications may be practiced within the scope of the appended claims.

Claims
  • 1. A method to perform cardiopulmonary resuscitation in a patient in cardiac arrest, the method comprising: repetitively compressing the chest and permitting the chest to recoil a rate of about 60 to about 120 times/min;wherein with each compression a volume of respiratory gas is expelled from the lungs;wherein for a plurality of chest recoils, preventing respiratory gases from returning to the lungs by configuring a valve to remain closed during multiple successive chest decompressions such that there is a successive decrease in respiratory gases within the lungs thereby allowing more blood to enter the thoracic space; andperiodically actively expanding the lungs with an oxygen-containing gas.
  • 2. A method as in claim 1, wherein the step of permitting the chest to recoil comprises permitting the chest to recoil by its own resilience or by actively pulling upward on the chest to achieve complete chest wall recoil.
  • 3. A method as in claim 1, wherein during the chest recoil, intracranial pressures are decreased more rapidly and to a lower value thereby further increasing the duration and magnitude of cerebral perfusion pressure, and wherein the valve opens to permit air to flow into the lungs through the valve if the patient begins to breathe.
  • 4. A method as in claim 1, wherein the volume of respiratory gas expelled over a series of chest compression/recoil cycles is in the range from about 1 to about 15 cc/kg.
  • 5. A method as in claim 1, further comprising expelling the volume of respiratory gas from the chest against a low level of fixed or variable resistance that is in the range from about 0 to about 10 cm H2O.
  • 6. A method as in claim 1, further comprising providing visual or audible instructions to a rescuer as to a desired compression or ventilation rate.
  • 7. A method as in claim 1, further comprising measuring patient gas volumes or airway pressures, and using a controller having a memory and a computer processor to estimate the rate and depth of chest compressions by evaluating variations in the amount of gasses delivered or airway pressure produced by positive-pressure ventilations to the amount of gasses expelled or airway pressures produced during chest compressions or chest recoil.
  • 8. A device to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest, the device comprising: a housing having a rescuer port and a patient port, an exhalation one way valve and an inhalation one way valve which is biased in a closed position;wherein the housing and one way valves are configured such that a volume of respiratory gas expelled from the lungs during each chest compression enters the housing through the patient port, passes through the exhalation one way valve and exits the rescuer port, and wherein, when the chest wall recoils, oxygen containing gasses are prevented from entering the lungs through the rescuer port by both of the one way valves;a ventilation source to inject an oxygen-containing gas into the housing, to open the inhalation one way valve, and to pass through the rescuer port and to the patient to periodically expand the lungs with the oxygen-containing gases;wherein the inhalation one way valve is configured to remain closed during multiple, successive chest decompressions so that respiratory gasses are prevented from reaching the lungs through the inhalation one way valve over successive chest compression/chest recoil cycles to successively decrease the volume of respiratory gasses in the lungs thereby allowing more blood to enter the thoracic space;wherein the inhalation one way valve is configured to open when a pressure in the intrathoracic space is about −10 cm H2O; andwhen the patient gasps or begins spontaneous breathing, the inhalation one way valve is configured to open and allow air to enter the patient's lungs.
  • 9. A device to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest, the device comprising: a housing having a rescuer port and a patient port;a valve system disposed in the housing;wherein the housing and the valve system are configured such that a volume of respiratory gas expelled from the lungs during each chest compression enters the housing through the patient port, passes through the valve system and exits the rescuer port, and wherein, when the chest wall recoils, oxygen containing gases are prevented from entering the lungs through the patient port by the valve system;a ventilation source to inject an oxygen-containing gas into the housing, to pass through the valve system, and to pass through the patient port and to the patient to periodically expand the lungs with the oxygen-containing gases;at least one physiological sensor that is selected from a group consisting of airway pressure sensors, carbon dioxide sensors, electrocardiogram signal sensors, and impedance sensors; anda communication system to permit signals from the physiological sensor to be transmitted to a CPR device or to the person performing CPR and used during resuscitation to provide feedback for at least one of how to perform CPR, an optimal time to actively inflate the lungs with respiratory gases and an optimal time to defibrillate, and further comprising at least one indicator that is configured to assist a rescuer in performing CPR.
  • 10. A device as in claim 9, wherein the valve system includes at least one valve selected from a group consisting of a check valve, a spring valve, a duck valve and an electronically-controlled valve.
  • 11. A device as in claim 9, wherein the ventilation source is selected from a group consisting of mouth-to-mouth ventilation, a mouth-mask, a resuscitator bag, an automatic ventilator, a semi-automatic ventilator, a body cuirass and an iron-lung device.
  • 12. A device as in claim 9, wherein the valve system includes a means to impede the exodus of respiratory gases from the lungs with a fixed or variable resistance that is in the range from about 0 to about 10 cm H2O.
  • 13. A device as in claim 9, further comprising a supply system to deliver a low flow and volume of continuous oxygen into the lungs which is less than the volume of respiratory gases expelled with successive chest compressions so that the number of times that the lungs are expanded with oxygen-containing gases is reduced by the low level of continuous oxygen insufflation.
  • 14. A device as in claim 9, wherein the valve system comprises a pair of one way valves that are separately configured to open with opposite gas flows through the housing.
  • 15. A device as in claim 9, further comprising a monitoring system to measure the total volume expelled from the lungs while performing CPR.
  • 16. A device to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest, the device comprising: a housing having a rescuer port and a patient port, an exhalation one way valve and an inhalation one way valve which is biased in a closed position;wherein the housing and one way valves are configured such that a volume of respiratory gas expelled from the lungs during each chest compression enters the housing through the patient port, passes through the exhalation one way valve and exits the rescuer port;a ventilation source to inject an oxygen-containing gas into the housing, to open the inhalation one way valve, and to pass through the rescuer port and to the patient to periodically expand the lungs with the oxygen-containing gases;a sensor that is associated with the housing to measure gas volumes or airway pressure; anda controller that is configured to receive measurements from the sensor and to estimate the rate and depth of chest compressions by evaluating variations in the amount of gasses delivered or airway pressure produced by positive-pressure ventilations to the amount of gasses expelled or airway pressures produced during chest compressions.
  • 17. A device as in claim 16, wherein the controller is configured to send instructions to produce visual instructions as to a desired compression and/or ventilation rate.
  • 18. A device as in claim 16, wherein, when the chest wall recoils, oxygen containing gasses are prevented from entering the lungs through the rescuer port by both of the one way valves, and wherein the inhalation one way valve is configured to remain closed during multiple, successive chest decompressions so that respiratory gasses are prevented from reaching the lungs through the inhalation one way valve over successive chest compression/chest recoil cycles to successively decrease the volume of respiratory gasses in the lungs thereby allowing more blood to enter the thoracic space.
  • 19. A system to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest, the device comprising: a housing having: a rescuer port; anda patient port; anda valve system disposed in the housing;wherein the housing and the valve system are configured such that respiratory gas expelled from a patient's lungs during a chest compression enters the housing through the patient port, passes through the valve system, and exits the rescuer port, and wherein, when the chest wall recoils, oxygen containing gasses are prevented from entering the patient's lungs through the patient port by the valve system;wherein the valve system is configured to remain closed during multiple, successive chest decompressions so that respiratory gasses are prevented from reaching the patient's lungs over successive chest compression/chest recoil cycles to successively decrease the volume of respiratory gasses in the lungs thereby allowing more blood to enter the thoracic space; andwherein the valve system is configured to open and allow air to enter the patient's lungs if the patient gasps or begins spontaneous breathing;at least one of an airway pressure sensor, carbon dioxide sensor, electrocardiogram signal sensor, and an impedance sensor;at least one indicator that is configured to assist a rescuer in performing CPR; anda communication system to permit signals from the at least one of an airway pressure sensor, carbon dioxide sensor, electrocardiogram signal sensor, and an impedance sensor to be transmitted to a CPR device or to the rescuer performing CPR to provide feedback for at least one of how to perform CPR, an optimal time to actively inflate the lungs with respiratory gases and an optimal time to defibrillate.
  • 20. The system of claim 19, wherein the indicator is a timing light.
  • 21. The system of claim 19, further comprising a ventilation source to inject an oxygen-containing gas into the housing and through the valve system to pass oxygen-containing gas through the patient port and to the patient to periodically expand the lungs with the oxygen-containing gas.
  • 22. The system of claim 21, wherein the device comprises a carbon dioxide sensor configured to provide an indication of a proper seal between the patient's trachea and the ventilation source.
  • 23. A system to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest, the device comprising: a housing having: a rescuer port; anda patient port; anda first valve and a second valve disposed in the housing; andat least one of an airway pressure sensor, carbon dioxide sensor, electrocardiogram signal sensor, and an impedance sensor disposed in at least one of the patient port, rescuer port, first valve, or second valve,wherein the housing and the valve system are configured such that respiratory gas expelled from a patient's lungs during a chest compression enters the housing through the patient port, passes through the first valve, and exits the rescuer port, and wherein, when the chest wall recoils, oxygen containing gasses are prevented from entering the patient's lungs through the patient port by both of the first valve and the second valve;wherein the first valve and second valve are biased in a closed position such that respiratory gasses are prevented from reaching the patient's lungs over successive chest compression/chest recoil cycles to successively decrease the volume of respiratory gasses in the lungs; andwherein the second valve is configured to open and allow air to enter the patient's lungs through the patient port if: the patient gasps or begins spontaneous breathing; oran oxygen-containing gas is injected into the housing through the rescuer port.
  • 24. The device of claim 23, wherein the first valve and the second valve are one-way valves, such that the first valve only permits airflow from the patient port to the rescuer port, and the second valve only permits airflow from the rescuer port to the patient port.
  • 25. The device of claim 24, wherein the first valve and the second valve are check valves, and wherein the first valve is biased in a closed position unless and until gas exiting the patient's lungs through the patient port exert a pressure on the valve that is less than about 20 cm H2O, and wherein the second valve is biased in a closed position unless and until a pressure of from about −5 to about −10 mmHg is reached in the patient's thorax.
  • 26. The device of claim 23, wherein the device comprises a carbon dioxide sensor configured to provide an indication of a proper seal between the patient's trachea and a ventilation source in fluid communication with the rescuer port.
  • 27. A device to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest, the device comprising: a housing having a rescuer port and a patient port;an exhalation one way valve biased in a closed position; andan inhalation one way valve biased in a closed position;wherein the housing and one way valves are configured such that a volume of respiratory gas expelled from the lungs during each chest compression enters the housing through the patient port, passes through the exhalation one way valve and exits the rescuer port;a sensor that is associated with the housing configured to provide an indication of a proper seal between the patient's trachea and a ventilation source in fluid communication with the rescuer port; anda controller that is configured to receive measurements from the sensor and to estimate the rate and depth of chest compressions by evaluating variations in the amount of gasses delivered or airway pressure produced by positive-pressure ventilations to the amount of gasses expelled or airway pressures produced during chest compressions.
  • 28. The device of claim 27, wherein the device comprises a carbon dioxide sensor configured to provide an indication of a proper seal between the patient's trachea and a ventilation source in fluid communication with the rescuer port.
  • 29. The device of claim 27, wherein the inhalation and exhalation one way valves include impede the exodus of respiratory gases from the lungs with a fixed or variable resistance that is in the range of from about 0 to about 10 cm H2O.
  • 30. The device of claim 27, wherein the sensor is a carbon dioxide sensor.
  • 31. The device of claim 27, wherein the sensor measures gas volumes and/or airway pressure.
CROSS REFERENCES TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 13/411,230, now U.S. Pat. No. 8,985,098, filed Mar. 2, 2012, which is a continuation in-part of U.S. patent application Ser. No. 11/871,879, now U.S. Pat. No. 8,151,790, filed Oct. 12, 2007, which claims the benefit of U.S. Provisional Application No. 60/912,891, filed Apr. 19, 2007, the complete disclosures of which are herein incorporated by reference.

US Referenced Citations (378)
Number Name Date Kind
1848232 Swope et al. Mar 1932 A
2325049 Frye et al. Jul 1943 A
2774346 Halliburton Dec 1956 A
2854982 Pagano Oct 1958 A
2904898 Marsden Sep 1959 A
3009266 Brook Nov 1961 A
3049811 Ruben Aug 1962 A
3068590 Padellford Dec 1962 A
3077884 Batrow et al. Feb 1963 A
3191596 Bird et al. Jun 1965 A
3199225 Robertson et al. Aug 1965 A
3209469 James Oct 1965 A
3216413 Mota Nov 1965 A
3274705 Breakspear Sep 1966 A
3276147 Padellford Oct 1966 A
3307541 Hewson Mar 1967 A
3357426 Cohen Dec 1967 A
3420232 Bickford Jan 1969 A
3459216 Bloom et al. Aug 1969 A
3467092 Bird et al. Sep 1969 A
3509899 Hewson May 1970 A
3515163 Freeman Jun 1970 A
3523529 Kissen Aug 1970 A
3552390 Muller Jan 1971 A
3562924 Baerman et al. Feb 1971 A
3562925 Baermann et al. Feb 1971 A
3568333 Clark Mar 1971 A
3662751 Barkalow et al. May 1972 A
3669108 Sundblom et al. Jun 1972 A
3734100 Walker et al. May 1973 A
3739776 Bird et al. Jun 1973 A
3794043 McGinnis Feb 1974 A
3815606 Mazal Jun 1974 A
3834383 Weigl et al. Sep 1974 A
3872609 Smrcka Mar 1975 A
3874093 Garbe Apr 1975 A
3875626 Tysk et al. Apr 1975 A
3933171 Hay Jan 1976 A
3949388 Fuller Apr 1976 A
3973564 Carden Aug 1976 A
3981398 Boshoff Sep 1976 A
3993059 Sjostrand Nov 1976 A
4037595 Elam Jul 1977 A
4041943 Miller Aug 1977 A
4054134 Kritzer Oct 1977 A
4077400 Harrigan Mar 1978 A
4077404 Elam Mar 1978 A
4095590 Harrigan Jun 1978 A
4166458 Harrigan Sep 1979 A
4193406 Jinotti Mar 1980 A
4198963 Barkalow Apr 1980 A
4226233 Kritzer Oct 1980 A
4237872 Harrigan Dec 1980 A
4240419 Furlong et al. Dec 1980 A
4259951 Chernack et al. Apr 1981 A
4262667 Grant Apr 1981 A
4297999 Kitrell Nov 1981 A
4298023 McGinnis Nov 1981 A
4316458 Hammerton-Fraser Feb 1982 A
4320754 Watson et al. Mar 1982 A
4326507 Barkalow Apr 1982 A
4331426 Sweeney May 1982 A
4349015 Alferness Sep 1982 A
4360345 Hon Nov 1982 A
4397306 Weisfeldt Aug 1983 A
4424806 Newman et al. Jan 1984 A
4446864 Watson et al. May 1984 A
4448192 Stawitcke et al. May 1984 A
4449526 Elam May 1984 A
4481938 Lindley Nov 1984 A
4501582 Schulz Feb 1985 A
4513737 Mabuchi Apr 1985 A
4519388 Schwanbom et al. May 1985 A
4520811 White et al. Jun 1985 A
4533137 Sonne Aug 1985 A
4543951 Phuc Oct 1985 A
4588383 Parker et al. May 1986 A
4598706 Darowski et al. Jul 1986 A
4601465 Roy Jul 1986 A
4602653 Ruiz-Vela et al. Jul 1986 A
4637386 Baum Jan 1987 A
4738249 Linman et al. Apr 1988 A
4774941 Cook Oct 1988 A
4797104 Laerdal et al. Jan 1989 A
4807638 Sramek Feb 1989 A
4809683 Hanson Mar 1989 A
4827935 Geddes et al. May 1989 A
4828501 Ingenito et al. May 1989 A
4863385 Pierce Sep 1989 A
4881527 Lerman Nov 1989 A
4898166 Rose et al. Feb 1990 A
4898167 Pierce et al. Feb 1990 A
4928674 Halperin et al. May 1990 A
4932879 Ingenito et al. Jun 1990 A
4971042 Lerman Nov 1990 A
4971051 Toffolon Nov 1990 A
4984987 Brault et al. Jan 1991 A
5014698 Cohen May 1991 A
5016627 Dahrendorf et al. May 1991 A
5029580 Radford et al. Jul 1991 A
5042500 Norlien et al. Aug 1991 A
5050593 Poon Sep 1991 A
5056505 Warwick et al. Oct 1991 A
5083559 Brault et al. Jan 1992 A
5109840 Daleiden May 1992 A
5119825 Huhn Jun 1992 A
5150291 Cummings et al. Sep 1992 A
5163424 Kohnke Nov 1992 A
5183038 Hoffman et al. Feb 1993 A
5184620 Cudahy et al. Feb 1993 A
5188098 Hoffman et al. Feb 1993 A
5193529 Labaere Mar 1993 A
5193544 Jaffe Mar 1993 A
5195896 Sweeney et al. Mar 1993 A
5217006 McCulloch Jun 1993 A
5231086 Sollevi Jul 1993 A
5235970 Augustine Aug 1993 A
5238409 Brault et al. Aug 1993 A
5239988 Swanson Aug 1993 A
5263476 Henson Nov 1993 A
5265595 Rudolph Nov 1993 A
5282463 Hammersley Feb 1994 A
5295481 Geeham Mar 1994 A
5301667 McGrail et al. Apr 1994 A
5305743 Brain Apr 1994 A
5306293 Zacouto Apr 1994 A
5312259 Flynn May 1994 A
5313938 Garfield May 1994 A
5316907 Lurie et al. May 1994 A
5330514 Egelandsdal et al. Jul 1994 A
5335654 Rapoport Aug 1994 A
5353788 Miles Oct 1994 A
5355879 Brain Oct 1994 A
5359998 Lloyd Nov 1994 A
5366231 Hung Nov 1994 A
5377671 Biondi et al. Jan 1995 A
5383786 Kohnke Jan 1995 A
5388575 Taube Feb 1995 A
5392774 Sato Feb 1995 A
5395399 Rosenwald Mar 1995 A
5397237 Dhont et al. Mar 1995 A
5398714 Price Mar 1995 A
5413110 Cummings et al. May 1995 A
5423685 Adamson et al. Jun 1995 A
5423772 Lurie et al. Jun 1995 A
5425742 Joy Jun 1995 A
5437272 Fuhrman Aug 1995 A
5452715 Boussignac Sep 1995 A
5454779 Lurie Oct 1995 A
5458562 Cooper Oct 1995 A
5468151 Egelandsdal et al. Nov 1995 A
5474533 Ward et al. Dec 1995 A
5477860 Essen-Moller Dec 1995 A
5490820 Schock et al. Feb 1996 A
5492115 Abramov et al. Feb 1996 A
5492116 Scarberry et al. Feb 1996 A
5496257 Kelly Mar 1996 A
5517986 Starr et al. May 1996 A
5544648 Fischer, Jr. Aug 1996 A
5549106 Gruenke et al. Aug 1996 A
5549581 Lurie et al. Aug 1996 A
5551420 Lurie et al. Sep 1996 A
5557049 Ratner Sep 1996 A
5580255 Flynn Dec 1996 A
5582182 Hillsman Dec 1996 A
5588422 Lurie et al. Dec 1996 A
5593306 Kohnke Jan 1997 A
5614490 Przybelski Mar 1997 A
5617844 King Apr 1997 A
5618665 Lurie et al. Apr 1997 A
5619665 Emma Apr 1997 A
5628305 Melker May 1997 A
5632298 Artinian May 1997 A
5643231 Lurie et al. Jul 1997 A
5645522 Lurie et al. Jul 1997 A
5657751 Karr, Jr. Aug 1997 A
5678535 DiMarco Oct 1997 A
5685298 Idris Nov 1997 A
5692498 Lurie et al. Dec 1997 A
5697364 Chua et al. Dec 1997 A
5701883 Hete et al. Dec 1997 A
5701889 Danon Dec 1997 A
5704346 Inoue Jan 1998 A
5720282 Wright Feb 1998 A
5722963 Lurie et al. Mar 1998 A
5730122 Lurie Mar 1998 A
5735876 Kroll et al. Apr 1998 A
5738637 Kelly et al. Apr 1998 A
5743864 Baldwin, II Apr 1998 A
5782883 Kroll et al. Jul 1998 A
5794615 Estes Aug 1998 A
5806512 Abramov et al. Sep 1998 A
5814086 Hirschberg et al. Sep 1998 A
5817997 Wernig Oct 1998 A
5823185 Chang Oct 1998 A
5823787 Gonzalez et al. Oct 1998 A
5827893 Lurie et al. Oct 1998 A
5832920 Field Nov 1998 A
5853292 Eggert et al. Dec 1998 A
5881725 Hoffman et al. Mar 1999 A
5885084 Pastrick et al. Mar 1999 A
5891062 Schock et al. Apr 1999 A
5896857 Hely et al. Apr 1999 A
5916165 Duchon et al. Jun 1999 A
5919210 Lurie et al. Jul 1999 A
5927273 Federowicz et al. Jul 1999 A
5937853 Strom Aug 1999 A
5941710 Lampotang et al. Aug 1999 A
5975081 Hood et al. Nov 1999 A
5977091 Nieman et al. Nov 1999 A
5984909 Lurie et al. Nov 1999 A
5988166 Hayek Nov 1999 A
6001085 Lurie et al. Dec 1999 A
6010470 Albery et al. Jan 2000 A
6029667 Lurie Feb 2000 A
6042532 Freed et al. Mar 2000 A
6062219 Lurie et al. May 2000 A
6078834 Lurie et al. Jun 2000 A
6086582 Altman et al. Jul 2000 A
6123074 Hete et al. Sep 2000 A
6131571 Lampotang et al. Oct 2000 A
6155257 Lurie et al. Dec 2000 A
6155647 Albecker, III Dec 2000 A
6165105 Boutellier et al. Dec 2000 A
6167879 Sievers et al. Jan 2001 B1
6174295 Cantrell et al. Jan 2001 B1
6176237 Wunderlich et al. Jan 2001 B1
6193519 Eggert et al. Feb 2001 B1
6209540 Sugiura et al. Apr 2001 B1
6224562 Lurie et al. May 2001 B1
6234916 Carusillo et al. May 2001 B1
6234985 Lurie et al. May 2001 B1
6277107 Lurie Aug 2001 B1
6296490 Bowden Oct 2001 B1
6312399 Lurie et al. Nov 2001 B1
6334441 Zowtiak et al. Jan 2002 B1
6356785 Snyder et al. Mar 2002 B1
6374827 Bowden et al. Apr 2002 B1
6390996 Halperin May 2002 B1
6425393 Lurie et al. Jul 2002 B1
6439228 Hete et al. Aug 2002 B1
6459933 Lurie et al. Oct 2002 B1
6463327 Lurie et al. Oct 2002 B1
6486206 Lurie Nov 2002 B1
6526970 DeVries et al. Mar 2003 B2
6526973 Lurie et al. Mar 2003 B1
6536432 Truschel Mar 2003 B2
6544172 Toeppen-Sprigg Apr 2003 B2
6555057 Barbut et al. Apr 2003 B1
6578574 Kohnke Jun 2003 B1
6584973 Biondi et al. Jul 2003 B1
6587726 Lurie et al. Jul 2003 B2
6595213 Bennarsten Jul 2003 B2
6604523 Lurie et al. Aug 2003 B2
6622274 Lee et al. Sep 2003 B1
6631716 Robinson et al. Oct 2003 B1
6656166 Lurie et al. Dec 2003 B2
6662032 Gavish et al. Dec 2003 B1
6676613 Cantrell et al. Jan 2004 B2
6729334 Baran May 2004 B1
6758217 Younes Jul 2004 B1
6776156 Lurie et al. Aug 2004 B2
6780017 Pastrick et al. Aug 2004 B2
6792947 Bowden Sep 2004 B1
6863656 Lurie Mar 2005 B2
6877511 DeVries et al. Apr 2005 B2
6935336 Lurie et al. Aug 2005 B2
6938618 Lurie et al. Sep 2005 B2
6986349 Lurie Jan 2006 B2
6988499 Holt et al. Jan 2006 B2
7011622 Kuyava et al. Mar 2006 B2
7032596 Thompson et al. Apr 2006 B2
7044128 Lurie et al. May 2006 B2
7066173 Banner et al. Jun 2006 B2
7082945 Lurie Aug 2006 B2
7096866 Be'eri et al. Aug 2006 B2
7174891 Lurie et al. Feb 2007 B2
7185649 Lurie Mar 2007 B2
7188622 Martin et al. Mar 2007 B2
7195012 Lurie Mar 2007 B2
7195013 Lurie Mar 2007 B2
7204251 Lurie Apr 2007 B2
7210480 Lurie et al. May 2007 B2
7220235 Geheb et al. May 2007 B2
7226427 Steen Jun 2007 B2
7275542 Lurie et al. Oct 2007 B2
7311668 Lurie Dec 2007 B2
7469700 Baran Dec 2008 B2
7487773 Li Feb 2009 B2
7500481 Delache et al. Mar 2009 B2
7594508 Doyle Sep 2009 B2
7650181 Freeman et al. Jan 2010 B2
7682312 Lurie Mar 2010 B2
7766011 Lurie Aug 2010 B2
7793659 Breen Sep 2010 B2
7836881 Lurie et al. Nov 2010 B2
7899526 Benditt et al. Mar 2011 B2
8011367 Lurie et al. Sep 2011 B2
8108204 Gabrilovich et al. Jan 2012 B2
8151790 Lurie et al. Apr 2012 B2
8210176 Metzger et al. Jul 2012 B2
8287474 Koenig et al. Oct 2012 B1
8388682 Hendricksen et al. Mar 2013 B2
8408204 Lurie Apr 2013 B2
8702633 Voss et al. Apr 2014 B2
8755902 Lurie et al. Jun 2014 B2
8939922 Strand et al. Jan 2015 B2
20010003984 Bennarsten et al. Jun 2001 A1
20010029339 Orr et al. Oct 2001 A1
20010047140 Freeman Nov 2001 A1
20020007832 Doherty Jan 2002 A1
20020069878 Lurie et al. Jun 2002 A1
20020104544 Ogushi et al. Aug 2002 A1
20020170562 Lurie et al. Nov 2002 A1
20020179090 Boussignac Dec 2002 A1
20030000526 Gobel Jan 2003 A1
20030037784 Lurie Feb 2003 A1
20030062040 Lurie et al. Apr 2003 A1
20030062041 Keith et al. Apr 2003 A1
20030192547 Lurie et al. Oct 2003 A1
20040016428 Lurie Jan 2004 A9
20040058305 Lurie et al. Mar 2004 A1
20040200473 Lurie et al. Oct 2004 A1
20040200474 Lurie Oct 2004 A1
20040210281 Dzeng et al. Oct 2004 A1
20040211415 Lurie Oct 2004 A1
20040211416 Lurie Oct 2004 A1
20040211417 Lurie Oct 2004 A1
20040231664 Lurie et al. Nov 2004 A1
20040267325 Geheb et al. Dec 2004 A1
20050016534 Ost Jan 2005 A1
20050075531 Loeb et al. Apr 2005 A1
20050126567 Lurie Jun 2005 A1
20050165334 Lurie Jul 2005 A1
20050199237 Lurie Sep 2005 A1
20050217677 Lurie et al. Oct 2005 A1
20050267381 Benditt et al. Dec 2005 A1
20060089574 Paradis Apr 2006 A1
20060129191 Sullivan et al. Jun 2006 A1
20060270952 Freeman et al. Nov 2006 A1
20070017523 Be-Eri et al. Jan 2007 A1
20070021683 Benditt et al. Jan 2007 A1
20070199566 Be'eri Aug 2007 A1
20070221222 Lurie Sep 2007 A1
20070277826 Lurie Dec 2007 A1
20080039748 Palmer et al. Feb 2008 A1
20080047555 Lurie et al. Feb 2008 A1
20080092891 Cewers Apr 2008 A1
20080097258 Walker Apr 2008 A1
20080097385 Vinten-Johansen et al. Apr 2008 A1
20080108905 Lurie May 2008 A1
20080255482 Lurie Oct 2008 A1
20080257344 Lurie et al. Oct 2008 A1
20090020128 Metzger et al. Jan 2009 A1
20090062701 Yannopoulos et al. Mar 2009 A1
20090076573 Burnett et al. Mar 2009 A1
20090164000 Shirley Jun 2009 A1
20090277447 Voss et al. Nov 2009 A1
20090299156 Simpson et al. Dec 2009 A1
20100000535 Wickham et al. Jan 2010 A1
20100179442 Lurie Jul 2010 A1
20100319691 Lurie et al. Dec 2010 A1
20110056491 Rumph et al. Mar 2011 A1
20110098612 Lurie Apr 2011 A1
20110160782 Lurie et al. Jun 2011 A1
20110201979 Voss et al. Aug 2011 A1
20110297147 Lick et al. Dec 2011 A1
20120016279 Banville et al. Jan 2012 A1
20120203147 Lurie et al. Aug 2012 A1
20120302908 Hemnes et al. Nov 2012 A1
20120330199 Lurie et al. Dec 2012 A1
20120330200 Voss et al. Dec 2012 A1
20130118498 Robitaille et al. May 2013 A1
20130172768 Lehman Jul 2013 A1
20130231593 Yannopoulos et al. Sep 2013 A1
20130269701 Lurie Oct 2013 A1
20140005566 Homuth et al. Jan 2014 A1
20140048061 Yannopoulos et al. Feb 2014 A1
Foreign Referenced Citations (46)
Number Date Country
1487792 Oct 1992 AU
60539 Nov 1994 AU
687942 May 1995 AU
668771 Aug 1963 CA
2077608 Mar 1993 CA
2214887 Jul 2008 CA
1183731 Jun 1998 CN
2453490 May 1975 DE
4308493 Sep 1994 DE
0029352 May 1981 EP
0139363 May 1985 EP
0245142 Nov 1987 EP
0367285 May 1990 EP
0411714 Feb 1991 EP
0509773 Oct 1992 EP
0560440 Sep 1993 EP
0623033 Nov 1994 EP
1344862 Jan 1974 GB
1465127 Feb 1977 GB
2117250 Oct 1983 GB
2139099 Nov 1984 GB
2005000675 Jan 2005 JP
2006524543 Nov 2006 JP
2007504859 Mar 2007 JP
9005518 May 1990 WO
9302439 Feb 1993 WO
9321982 Nov 1993 WO
9426229 Nov 1994 WO
9513108 May 1995 WO
9528193 Oct 1995 WO
9628215 Sep 1996 WO
9820938 May 1998 WO
9947197 Sep 1999 WO
9963926 Dec 1999 WO
0020061 Apr 2000 WO
0102049 Jan 2001 WO
0170092 Sep 2001 WO
0170332 Sep 2001 WO
02092169 Nov 2002 WO
2004096109 Nov 2004 WO
2006088373 Aug 2006 WO
2008147229 Dec 2008 WO
2010044034 Apr 2010 WO
2013064888 May 2013 WO
2013096495 Jun 2013 WO
2014026193 Feb 2014 WO
Non-Patent Literature Citations (55)
Entry
US 5,584,866, 12/1996, Kroll et al. (withdrawn)
Advanced Circulatory Systems, Inc.; ResQPOD® Circulatory Enhancer: Strengthening the Chain of Survival (#49-0336-000, 01) [Brochure]; 2006; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; ResQPOD® Circulatory Enhancer: Strengthening the Chain of Survival (#49-0336-000, 02) [Brochure]; 2006; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; Introducing ResQPOD® (#49-0324-000; 01) [Brochure]; 2005; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; ResQPOD® Perfusion on Demand: ResQPOD Impedance Threshold Device (#49-0324-001, 03) [Brochure]; 2010; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; ResQPOD® Impedance Threshold Device 10.0: Strengthening the Chain of Survival (#49-0336-000, 03) [Brochure]; 2009; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; ResQPOD® Perfusion on Demand: ResQPOD Impedance Threshold Device (#49-0324-001, 02) [Brochure]; 2009; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; ResQPOD® Impedance Threshold Device: Strengthening the Chain of Survivial (#49-0336-000, 04) [Brochure]; 2010; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; ResQPOD® Impedance Threshold Device: Strengthening the Chain of Survival (#49-0336-000, 05) [Brochure] 2010; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; ResQPOD® Perfusion on Demand: ResQPOD Impedance Threshold Device (#49-0324-001, 04) [Brochure]; 2011; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; ResQPOD® Perfusion on Demand: ResQPOD Impedance Threshold Device (#49-0324-001, 05) [Brochure] 2011; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; ResQPOD® ITD: Stengthening the Chain of Survivial (#49-0336-000, 06) [Brochure]; 2011; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; Early Intervention is Life-Saving in Cardiac Arrest (#49-0864-000-01) [Brochure]; Aug. 2011; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; Early Intervention is Life-Saving in Cardiac Arrest (#49-0864-000-02) [Brochure]; Aug. 2011; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; Benefits of the ResQPOD Based Upon the ROC PRIMED Study (#49-0864-000-03) [Brochure]; Jan. 2012; 2 pages; Roseville, MN.
Advanced Circulatory Systems, Inc.; Benefits of ResQPOD Based Upon the ROC PRIMED Study (#49-0864-000, 04) [Brochure]; Mar. 2012; 2 pages; Roseville, MN.
AMBU International A/S; Directions for use of Ambu® CardioPump™; 8 pages.
Aufderheide et al.; Hyperventilation-induced hypotension during cardiopulmonary resuscitation; Circulation; 2004; pp. 1960-1965; vol. 109; No. 16.
Aufderheide et al.; Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: A randomized trial; Lancet; 2011, pp. 301-311, vol. 377.
Christenson; Abdominal Compressions During CPR: Hemodynamic Effects of Altering Timing and Force; The Journal of Emergency Medicine; 1992; pp. 257-266; vol. 10.
Cohen et al.; Active-Compression-Decompression: A Novel Method of Cardiopulmonary Resuscitation; American Heart Journal; 1992; pp. 1145-1150; vol. 126; No. 5.
Cohen et al.; Active Compression-Decompression: A New Method of Cardiopulmonary Resuscitations; The Journal of the American Medical Association; Jun. 3, 1992; pp. 2916-2923; vol. 267; No. 21.
Dupuis; Ventilators: Theory and Clinical Application; Jan. 1986; 7 pages; Mosby Company.
Geddes et al.; Electrically Produced Artificial Ventilation; Medical Instrumentation; 1988; pp. 263-271; vol. 22; No. 5.
Geddes et al.; Optimum Stimulus Frequency for Contracting the Inspiratory Muscles with Chest-Surface Electrodes to Produce Artificial Respiration; Annals of Biomedical Engineering; 1990; pp. 103-108; vol. 18.
Geddes et al.; Inspiration Produced by Bilateral Electromagnetic, Cervical Phrenic Nerve Stimulation in Man; IEEE Transactions on Biomedical Engineering; Oct. 1991; pp. 1047-1048; vol. 38; No. 9.
Geddes et al.; Electroventilation—A Missed Opportunity?; Biomedical Instrumentation & Technology; 1998; pp. 401-414; vol. 32.
Glenn et al.; Diaphragm Pacing by Electrical Stimulation of the Phrenic Nerve; Neurosurgery; 1985; pp. 974-984; vol. 17; No. 6.
Glenn et al.; Twenty Years of Experience in Phrenic Nerve Stimulation to Pace the Diaphragm; PACE; 1986; pp. 780-784; vol. 9.
International Search Report and Written Opinion of PCT/US2004/027772; mailed on Mar. 11, 2005; 5 pages.
International Search Report and Written Opinion of PCT/US2008/060367; mailed on Sep. 23, 2008; 11 pages.
Kotze et al.; Diaphragm Pacing in the Treatment of Ventilatory Failure; San Deel; Aug. 17, 1995; pp. 223-224; vol. 68.
Laghi et al.; Comparison of Magnetic and Electrical Phrenic Nerve Stimulation in Assessment of Diaphragmatic Contractility; American Physiological Society; 1996; pp. 1731-1742.
Lindner et al.; Effects of Active Compression-Decompression Resuscitation of Myocardial and Cerebral Blood Flow in Pigs; Department of Anesthesiology and Critical Care Medicine; University of Ulm, Germany; Oct. 7, 1993; pp. 1254-1263; vol. 88; No. 3.
Lurie et al.; Regulated to Death: The Matter of Informed Consent for Human Experimentation in Emergency Resuscitation Research; Cardiac Arrhythmia Center at the University of Minnesota; PACE; Jul. 1995; pp. 1443-1447; vol. 18.
Mushin et al.; Automated Ventilation of the Lungs—The Lewis-Leigh Inflating Valve; Blackwell Scientfic; p. 838; Oxford, UK.
Search Report of AU 2008243018; mailed on Sep. 18, 2012; 3 pages.
Segal, et al.; Ischemic Postconditioning at the Initiation of Cardiopulmonary Resuscitation Facilitates Cardiac and Cerebral Recovery After Prolonged Untreated Ventricular Fibrillation; Resuscitation; 2012; 7 pages.
Supplementary Partial European Search Report for European Patent Application No. EP 08745882 (PCT/US2008/060367); mailed on Feb. 26, 2014; 8 pages.
Yannopoulos, et al; Intrathoracic Pressure Regulator During Continuous-Chest-Compression Advanced Cardiac Resuscitation Improves Vital Organ Perfusion Pressures in a Porcine Model of Cardiac Arrest; Circulation; 2005; pp. 803-811.
Yannopoulos et al.; Intrathoracic pressure regulation improves vital organ perfusionn pressures in normovolemic and hypovolemic pigs; Resuscitation; 2006; pp. 445-453; vol. 70.
Yannopoulos et al., Intrathoracic Pressure Regulation Improves 24-Hour Survival in a Porcine Model of Hypovolemic Shock; Anesthesia & Analgesia; ITPR and Survival in Hypovolemic Shock; 2007; pp. 157-162; vol. 104; No. 1.
Yannopoulos et al.; Sodium nitroprusside enhanced cardiopulmonary resuscitation improves survival with good neurological function in a porcine model of prolonged cardiac arrest; Critical Care Medicine; 2011; 6 pages; vol. 39; No. 6.
Yannopoulos et al.; Controlled pauses at the initiation of sodium nitroprusside-enhanced cardiopulmonary resuscitation facilitate neurological and cardiac recovery after 15 minutes of untreated ventricular fibrillation; Critical Care Medicine; 2012; 8 pages; vol. 40, No. 5.
Advanced Circulatory Systems, Inc. (Jan. 2014), Emerging Data: The Resuscitation Outcomes Consortium (ROC) PRIMED Study on the Efficacy of the ITD (#49-0864-000,06) [Brochure], Roseville, MN:Advanced Circulatory Systems, Inc. 2 pages.
Advanced Circulatory Systems, Inc. (Jan. 2013), Emerging Data: The Resuscitation Outcomes Consortium (ROC) Primed Study on the Efficacy of the ITD (#49-0864-000,05) [Brochure], Roseville, MN:Advanced Circulatory Systems, Inc. 2 pages.
Advanced Circulatory Systems, Inc. (2013), ResQPOD More than a Heartbeat (#49-0336-000,08) [Brochure], Roseville, MN:Advanced Circulatory Systems, Inc. 2 pages.
Babbs, Charles F.MD. PhD., CPR Techniques that Combine Chest and AbdominalCompression and Decompression: Hemodynamic Insights from a Spreadsheet Model, Circulation,1999, pp. 2146-2152.
Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiac Care, JAMA, 1992:268; 5 pages.
Lurie, K., et. al., Comparison of a 10-Breaths-Per-Minute Versus a 2-Breaths-Per-Minute Strategy During Cardiopulmonary Resuscitation in a Porcine Model of Cardiac Arrest,: Respiratory Care, 2008, vol. 53, No. 7, pp. 362-870.
Michigan Instruments, Inc.Thumper 1007CC Continuous Compression Cardiopulmonary Resuscitation System, obtained online Jul. 15, 2006 at http://WwW.michiganinstruments.com/resus-thumper.htm, 2 pages.
Schultz, J., et al., “Sodium nitroprusside enhanced cardiopulmonary resuscitation (SNPeCPR) improves vitalorgan perfusion pressures and carotid blood flow in a porcine modelof cardiac arrest,” Resuscitation, 2012, vol. 83, pp. 374-377.
Shapiro et al., “Neurosurgical Anesthesia and Intracranial Hypertension” Chapter 54, Anesthesia; 3rd Edition; Ed. Ron Miller 1990.
Zhao et. al., Inhibation of a Myocardial Injury by Ischemic Postconditioning During RePerfusion:Comparison with Ischemic Preconditioning, Am. J. Physiol Heart Circ 285: H579-H588 (2003).
Zoll Autopulse Non-Invasive Cardiac Support Pump, obtained online on Jul. 15, 2006 at http://www.zoll.com/product.aspx?id=84,1 page.
Related Publications (1)
Number Date Country
20150202393 A1 Jul 2015 US
Provisional Applications (1)
Number Date Country
60912891 Apr 2007 US
Continuations (1)
Number Date Country
Parent 13411230 Mar 2012 US
Child 14635525 US
Continuation in Parts (1)
Number Date Country
Parent 11871879 Oct 2007 US
Child 13411230 US